Aktienanalyse wird geladen …
MDT · NYSE · Medical Devices · Irland
88,46 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 36,36 Mrd. | 4,8 Mrd. | 3,73 $ | 1,29 Mrd. | 5,2 Mio · 0,4 % | 7 Mio · 0,5 % | 65 % | 13,2 % | 4,21 $ | 0,35 $ | 2,84 $ |
| 2025 | 33,54 Mrd. | 4,66 Mrd. | 3,61 $ | 1,29 Mrd. | 4,8 Mio · 0,4 % | 45,1 Mio · 3,5 % | 65,3 % | 13,9 % | 4,02 $ | 0,33 $ | 2,80 $ |
| 2024 | 32,36 Mrd. | 3,68 Mrd. | 2,76 $ | 1,33 Mrd. | 4,4 Mio · 0,3 % | 7 Mio · 0,5 % | 65,3 % | 11,4 % | 3,91 $ | 0,30 $ | 2,76 $ |
| 2023 | 31,23 Mrd. | 3,76 Mrd. | 2,82 $ | 1,33 Mrd. | 4 Mio · 0,3 % | 22,6 Mio · 1,7 % | 65,7 % | 12 % | 3,44 $ | 0,27 $ | 2,72 $ |
| 2022 | 31,69 Mrd. | 5,04 Mrd. | 3,73 $ | 1,35 Mrd. | 4,1 Mio · 0,3 % | 6,7 Mio · 0,5 % | 68 % | 15,9 % | 4,42 $ | 0,27 $ | 2,52 $ |
| 2021 | 30,12 Mrd. | 3,61 Mrd. | 2,66 $ | 1,35 Mrd. | 3,9 Mio · 0,3 % | 1 Mio · 0,1 % | 65,2 % | 12 % | 3,61 $ | 0,25 $ | 2,32 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q3 2026 | 9,76 Mrd. | 1,47 Mrd. | 1,14 $ | 1,29 Mrd. | 15,1 % | 1,00 $ |
| Q2 2026 | 9,81 Mrd. | 1,24 Mrd. | 0,97 $ | — | 12,7 % | 1,62 $ |
| Q1 2026 | 9,02 Mrd. | 1,14 Mrd. | 0,89 $ | 1,29 Mrd. | 12,7 % | 1,78 $ |
| Q4 2025 | 8,96 Mrd. | 1,37 Mrd. | 1,07 $ | 1,29 Mrd. | 15,3 % | 0,35 $ |
| Q3 2025 | 8,58 Mrd. | 1,04 Mrd. | 0,81 $ | 1,29 Mrd. | 12,1 % | 0,45 $ |
| Q2 2025 | 8,93 Mrd. | 1,06 Mrd. | 0,82 $ | — | 11,8 % | 1,61 $ |
| Q1 2025 | 8,29 Mrd. | 1,29 Mrd. | 1,01 $ | 1,29 Mrd. | 15,6 % | 1,63 $ |
| Q4 2024 | 8,4 Mrd. | 1,27 Mrd. | 0,99 $ | 1,29 Mrd. | 15,1 % | 0,43 $ |
Could Medtronic (MDT)’s $700 Million Robotics Bet Unlock its Next Growth Engine?
Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic
Here's Why Medtronic (MDT) Fell More Than Broader Market
Medtronic (MDT): Q1 Beat Sparks Target Hikes, but Wall Street Splits on Re-Rating Case
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and healthcare solutions. Its portfolio spans cardiovascular care, neuroscience, medical surgical products, and diabetes management, supporting the diagnosis, treatment, and monitoring of a wide range of chronic and complex conditions. Medtronic supplies hospitals, clinics, physicians, and other healthcare providers with products such as cardiac rhythm devices, neuromodulation systems, surgical instruments, insulin pumps, and patient monitoring technologies. The company serves healthcare systems across the United States and international markets, making it an important participant in modern medical device supply chains and clinical care delivery. Headquartered in Dublin, Ireland, Medtronic plc focuses on technologies used in everyday care and advanced procedures, helping healthcare professionals address conditions across many specialties.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest MDT und jede andere Aktie unbegrenzt.